30 closest matches · ranked by relevance
Blood Pressure
Primary: Systolic Blood Pressure During Application of the CAT Tourniquets — 129; 76 mmHg
Hemorrhage · Vascular Injury
Primary: Radiologist Limb Occlusion Assessment — 19; 18; 8; 8 Participants — p=0.002
Arthritis Knee
Primary: Pain After TKA Measured by VAS Pain Survey on Focusmotion App — 2.8; 2.6 score on a scale
Healthy Subject
Primary: Change in Hand Volume Following Tourniquet Use — 15.0; 12.1; 12.5; 7.9 mL
Tourniquet Hypertension · Intraoperative Hypertension · Total Ankle Arthroplasty
Primary: Number of Subjects Experiencing Tourniquet Hypertension — 5; 14 Participants
Bleeding
Primary: Muscle Perfusion — 0.32; 0.10 IU/s
Anesthesia
Primary: The Hemoglobin (in g/dl) Levels — 12.2; 12.0; 11.9; 11.8 g/dl
Total Knee Arthroplasty · Ischemic Preconditioning · Postoperative Pain
Primary: Postoperative Pain at Rest and Exercise as Assessed by Visual Analogue Scale (VAS) Scores at 48h After Surgery — 1.75; .71; 3; 1.38 score on a scale — p=.043
Hypertension
Primary: Performance of Blood Pressure Referral Threshold — .841 proportion
Postpartum Haemorrhage (PPH)
Primary: Time to Bleeding Control After AAJT-S Device Application — 2 Minutes
Tourniquet
Primary: Peripheral IV Access Success Rate — 42; 43 Participants — p=0.95
Spinal Cord Injury · Autonomic Dysreflexia · Baroreceptor Integrity
Primary: Systolic Blood Pressure — 93.21; 107.00; 95.8; 93.84 mmHg
Hemorrhage
Primary: Effectiveness at Stopping Distal Pulse — 97; 27; 83; 93 percentage of participants
Transradial Angiogram
Primary: Bleeding Requiring Intervention After Initial Hemostasis Achieved — 2; 6; 3 participants — p=0.25
Knee Replacement
Primary: Isometric Quadriceps Strength — 11.58; 9.60 Nm/kg
Application Site Discomfort · Medical Device Discomfort
Primary: Time in Minutes That Tq Remained Inflated — 30.5; 22.4 Minutes
Hypertension
Primary: Median Dose Required to Increase the Systolic Blood Pressure (SBP) — 35; 43; 45 ng/kg/min
Radial Artery Injury at Wrist and Hand Level
Primary: Number of Patients Who Achieved Patent Hemostasis — 94; 122 Participants
Hypertension · Renal Failure Chronic Requiring Hemodialysis · Blood Pressure
Primary: Number of Participants Assessed for Intensive (110-140 mm Hg) and Standard (155-165mm Hg) Pre-dialysis Standardized BP Goal — 62; 64 participants
Hypertension
Primary: Blood Pressure — 103; 106; 94; 101 mmHg
Blood Pressure
Primary: Performance Comparison: NIBP Forearm Cuff Using SuperStat Algorithm vs. Invasive Radial Blood Pressure Reading — -0.94; 1.39 mmHg
Poor Peripheral Perfusion
Primary: MRI Based Radial Artery Measurement — 1.35 millimeters
Hypertension
Primary: Estimated Percentage of Participants in Blood Pressure Control at Baseline — 61; 59; 53; 64 % of particpants w/ controlled BP
Hypertension
Primary: Unadjusted and Adjusted Changes From Baseline in Systolic and Diastolic Blood Pressure at Weeks 1, 3, 6 — -1.2; -5.3; 0.8; -1.7 mmHg
Spinal Cord Injury
Primary: Seated Systolic Blood Pressure — 86; 100.4; 102.7; 101.3 mmHg
Radial Artery Incision Site Closure
Primary: Percentage of Participants With Bleeding — 0; 1 Participants
Brain Tumors
Primary: Failure of Drug to Control Systolic Blood Pressure (SBP) < 140 mmHg — 1; 11 participants
Hypotension
Primary: Rise in Systolic Blood Pressure Over the First 10 Minutes of Use Compared to Baseline — 5.9; 12.9 mm Hg
Intradialytic Hypertension
Primary: Endothelial Progenitor Cells — 0.052; 0.034; 0.027; 0.059 % of mononuclear cells
Hypertension · Emergencies · Asymptomatic Conditions
Primary: Number of Participants Who Died Within 7 Days After Discharge From the Emergency Department — 0; 0 participants